August 23, 2013 — Some of the most popular antibiotics have been linked to an increased risk of blood-sugar swings in patients with diabetes. According to a study published earlier this month in Clinical Infectious Diseases, the fluoroquinolone antibiotics Cipro, Avelox, and Levaquin have the highest risk of hyperglycemia (high blood-sugar) and hypoglycemia (low blood-sugar).
The study was conducted by researchers from Taiwan who analyzed records on 78,000 people with diabetes who were prescribed an antibiotic from January 2006 and November 2007. They looked at the rate of emergency room visits and hospitalizations for hyperglycemia and hypoglycemia within 30 days of using the antibiotic.
They found that the absolute risk was low — less than 1% of diabetic patients who took a fluoroquinolone. However, millions of people are prescribed these medications, and other antibiotics in the study were associated with lower risks for diabetics. The researchers warned:
“Our results identified moxifloxacin as the drug associated with the highest risk of hypoglycemia, followed by levofloxacin and ciprofloxacin. Other antibiotics should be considered if dysglycemia is a concern, such as a beta lactam or macrolide.”
The increased popularity of antibiotics in the fluoroquinolone class has led to concern about serious side effects. All of these drugs contain fluoride, a potent neurotoxin, as a central part of their chemical structure. Earlier this month, the U.S. Food and Drug Administration (FDA) issued warnings about peripheral neuropathy (nerve damage).
Fluoroquinolone antibiotics include:
- Cipro (ciprofloxacin)
- Factive (gemifloxacin)
- Levaquin (levofloxacin)
- Avelox (moxifloxacin)
- Noroxin (norfloxacin)
- And more
Do I have a Fluoroquinolone Antibiotic Lawsuit?
The Schmidt Firm, PLLC is currently accepting fluoroquinolone antibiotic induced injury cases in all 50 states. If you or somebody you know has been injured by Cipro, Levaquin, Avelox, or another antibiotic, you should contact our lawyers immediately for a free case consultation. Please use the form below to contact our Defective Drug Litigation Group or call toll free 24 hours a day at (866) 920-0753.
Attention Lawyers: We consider a referral from another law firm to be one of the greatest compliments. If your firm is interested in referring us a case or for us to send you a list of previous award judgments and/or average referral fees, please visit the Lawyer Referral section of our website.